Overcoming resistance of cancer stem cells

被引：21
|
作者：
Pignalosa, Diana [1 ]
Durante, Marco [1 ,2 ]
机构：
[1] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany
[2] Tech Univ Darmstadt, Darmstadt, Germany
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 05期
关键词：
D O I：
10.1016/S1470-2045(12)70196-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E187 / E188
页数：2
相关论文
共 50 条
  • [41] Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance
    Wang, Xinyi
    Liu, Zhikun
    Wang, Yuanjiang
    Gou, Shaohua
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (11) : 7933 - 7945
  • [42] Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer
    Otaegi-Ugartemendia, Maddalen
    Matheu, Ander
    Carrasco-Garcia, Estefania
    CANCERS, 2022, 14 (06)
  • [43] Influence of cancer stem cells on drug resistance in prostate cancer
    Castellon, E. A.
    Castillo, V.
    Valenzuela, R.
    Contreras, H. R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S75 - S75
  • [44] Cancer stem cells in colorectal cancer and the association with chemotherapy resistance
    Xue Lei
    Qinglian He
    Ziqi Li
    Qian Zou
    Pingrong Xu
    Haibing Yu
    Yuanlin Ding
    Wei Zhu
    Medical Oncology, 2021, 38
  • [45] Cancer resistance to immunotherapy: What is the role of cancer stem cells?
    Gupta, Gourab
    Merhej, George
    Saravanan, Shakthika
    Chen, Hexin
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 981 - 994
  • [46] Cancer stem cells in colorectal cancer and the association with chemotherapy resistance
    Lei, Xue
    He, Qinglian
    Li, Ziqi
    Zou, Qian
    Xu, Pingrong
    Yu, Haibing
    Ding, Yuanlin
    Zhu, Wei
    MEDICAL ONCOLOGY, 2021, 38 (04)
  • [47] Targeting Notch-1 and microRNAs crosstalk in breast cancer stem cells: A potential target for overcoming doxorubicin resistance.
    Sultan, Ahmed
    Hamed, Rana
    Yehia, Islam
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 109 - 110
  • [48] Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
    Anxo Rio-Vilariño
    Aiora Cenigaonandia-Campillo
    Ana García-Bautista
    Pedro A. Mateos-Gómez
    Marina I. Schlaepfer
    Laura del Puerto-Nevado
    Oscar Aguilera
    Laura García-García
    Carlos Galeano
    Irene de Miguel
    Juana Serrano-López
    Natalia Baños
    María Jesús Fernández-Aceñero
    Juan Carlos Lacal
    Enzo Medico
    Jesús García-Foncillas
    Arancha Cebrián
    British Journal of Cancer, 2024, 130 : 1402 - 1413
  • [49] Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
    Rio-Vilarino, Anxo
    Cenigaonandia-Campillo, Aiora
    Garcia-Bautista, Ana
    Mateos-Gomez, Pedro A.
    Schlaepfer, Marina I.
    del Puerto-Nevado, Laura
    Aguilera, Oscar
    Garcia-Garcia, Laura
    Galeano, Carlos
    de Miguel, Irene
    Serrano-Lopez, Juana
    Banos, Natalia
    Fernandez-Acenero, Maria Jesus
    Lacal, Juan Carlos
    Medico, Enzo
    Garcia-Foncillas, Jesus
    Cebrian, Arancha
    BRITISH JOURNAL OF CANCER, 2024, 130 (08) : 1402 - 1413
  • [50] Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells
    Hombach-Klonisch, Sabine
    Natarajan, Suchitra
    Thanasupawat, Thatchawan
    Medapati, Manoj
    Pathak, Alok
    Ghavami, Saeid
    Klonisch, Thomas
    FRONTIERS IN ENDOCRINOLOGY, 2014, 5
12345